Please assess the completion status of the following clinical trial:

Trial Title: Personalized Treatment Algorithms for Difficult-to-treat Asthma

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* History of provider-diagnosed asthma~* Meets one of the following definition for NAEPP guidelines uncontrolled moderate persistent asthma or severe persistent asthma in the past 12 months:~  * NAEPP step 3-4 with one of the following criteria in the past 12 months:~    * Two Asthma Control Test (ACT) scores \<20~   * 1 Urgent Care or Emergency Department visit or hospitalization for asthma~   * \>2 prednisone bursts~ * NAEPP step 5-6~* Current health insurance coverage at enrollment. This will be verified at V1 at the registration desk. If the family loses insurance during the study, the patient will be referred to the pulmonary social worker and financial office for assistance~* Reside at a primary home on average 5 out of 7 days a week.~* Primary home is within a 40 mile radius of Cincinnati Children's Base location or PI's discretion.~Exclusion Criteria:~* Received biologic therapy 6 months prior to enrollment~* Received systemic steroids 6 weeks prior to enrollment~* Active chronic disease apart from asthma or allergic disease~* Co-morbid lung disease~* Dependence on immunosuppressive drugs for a condition other than asthma~* Participant is pregnant~* Has a severe bleeding disorder~* Has significant developmental disability~* Share a bedroom with a currently enrolled Breath Warriors study participant

- Gender: ALL
- Minimum Age: 6 Years
- Maximum Age: 17 Years
- Healthy Volunteers: f

Study Arms:
- Personalized Treatment (Type: EXPERIMENTAL): Personalized asthma treatment plan based off of individual's asthma severity/control, personal and family medical history, history of environmental exposures, adherence, medical visits, biomarker assays, and home trigger assessment.~Study participants were prescribed recommended medications for the treatment of their asthma. These medications were prescribed through their insurance based of the of personalized treatment plan recommendation. Asthma controller medications may be increased based off of the participant's asthma control and the recommendation of the personalized plan. They would receive one of the asthma controller medications listed in the intervention.

Based on this trial design, predict the completion outcome and termination type (if applicable).